Literature DB >> 29247499

Cardiac output changes after osmotic therapy in neurosurgical and neurocritical care patients: a systematic review of the clinical literature.

Georgia Tsaousi1, Elisabetta Stazi2, Marco Cinicola2, Federico Bilotta2.   

Abstract

AIM: Osmotherapy constitutes a first-line intervention for intracranial hypertension management. However, hyperosmolar solutes exert various systematic effects, among which their impact on systemic haemodynamics is poorly clarified. This review aims to appraise the clinical evidence of the effect of mannitol and hypertonic saline (HTS) on cardiac performance in neurosurgical and neurocritical care patients.
METHOD: A database search was conducted to identify randomized clinical trials and observational studies reporting HTS or mannitol use in acute brain injury setting. The primary end-points were alterations of cardiac output (CO) and other haemodynamic variables, while the impact of osmotic agents on intracranial pressure, brain relaxation, plasma osmolality, electrolyte levels and urinary output constituted secondary outcomes.
RESULTS: Eight studies, enrolling 182 patients in total, were included. HTS exerted a more profound cardiac output augmentation than mannitol, but no distinct difference between groups occurred. Central venous pressure, stroke volume and stroke volume variation were favourably affected by both osmotic agents, whilst the reported changes in blood pressure were inconclusive. HTS infusion yielded a larger intracranial pressure reduction than mannitol but had an equivalent effect on brain relaxation. Mannitol presented a more potent diuretic effect than HTS. Effect on serum osmolality was alike in both osmotic agents, but contrary to HTS-promoted hypernatraemia, mannitol use induced transient hyponatraemia.
CONCLUSIONS: Mannitol or HTS administration seems to induce an enhancement of cardiac performance; being more prominent after HTS infusion. This effect combined with mannitol-induced enhancement of diuresis and HTS-promoted increase of plasma sodium concentration could partially explain the effects of osmotherapy on cerebral haemodynamics.
© 2017 The British Pharmacological Society.

Entities:  

Keywords:  cardiac output; cardiac performance; hypertonic saline; mannitol; osmotherapy; systemic haemodynamics

Mesh:

Substances:

Year:  2018        PMID: 29247499      PMCID: PMC5867072          DOI: 10.1111/bcp.13492

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  41 in total

Review 1.  Hypertonic saline--hydroxyethyl starch in trauma resuscitation.

Authors:  R Thompson; I Greaves
Journal:  J R Army Med Corps       Date:  2006-03       Impact factor: 1.285

Review 2.  Aquaporins in cerebrovascular disease: a target for treatment of brain edema?

Authors:  J Badaut; S Ashwal; A Obenaus
Journal:  Cerebrovasc Dis       Date:  2011-04-12       Impact factor: 2.762

3.  Effects of hypertonic saline - hydroxyethyl starch and mannitol on serum osmolality, dural tension and hemodynamics in patients undergoing elective neurosurgical procedures.

Authors:  Jiao Li; Baoguo Wang; Shuangyan Wang; Feng Mu
Journal:  Int J Clin Exp Med       Date:  2014-08-15

4.  Cerebral hemodynamic effects of 7.2% hypertonic saline in patients with head injury and raised intracranial pressure.

Authors:  F Munar; A M Ferrer; M de Nadal; M A Poca; S Pedraza; J Sahuquillo; A Garnacho
Journal:  J Neurotrauma       Date:  2000-01       Impact factor: 5.269

Review 5.  Hyperosmolar therapy for intracranial hypertension.

Authors:  Andrew Torre-Healy; Nicholas F Marko; Robert J Weil
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

6.  Effect of equiosmolar solutions of mannitol versus hypertonic saline on intraoperative brain relaxation and electrolyte balance.

Authors:  Irene Rozet; Nuj Tontisirin; Saipin Muangman; Monica S Vavilala; Michael J Souter; Lorri A Lee; M Sean Kincaid; Gavin W Britz; Arthur M Lam
Journal:  Anesthesiology       Date:  2007-11       Impact factor: 7.892

Review 7.  Role of hypertonic saline for the management of intracranial hypertension after stroke and traumatic brain injury.

Authors:  Lisa L Forsyth; Xi Liu-DeRyke; Dennis Parker; Denise H Rhoney
Journal:  Pharmacotherapy       Date:  2008-04       Impact factor: 4.705

Review 8.  Cerebral protection during neurosurgery and stroke.

Authors:  Rafael Badenes; Shaun E Gruenbaum; Federico Bilotta
Journal:  Curr Opin Anaesthesiol       Date:  2015-10       Impact factor: 2.706

9.  Hemodynamic changes after administration of mannitol measured by a noninvasive cardiac output monitor.

Authors:  Nikki Sabharwal; G S Umamaheswara Rao; Zulfiqar Ali; Muthuchellappan Radhakrishnan
Journal:  J Neurosurg Anesthesiol       Date:  2009-07       Impact factor: 3.956

10.  Comparison of 7.2% hypertonic saline - 6% hydroxyethyl starch solution and 6% hydroxyethyl starch solution after the induction of anesthesia in patients undergoing elective neurosurgical procedures.

Authors:  Liujiazi Shao; Baoguo Wang; Shuangyan Wang; Feng Mu; Ke Gu
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more
  1 in total

1.  Cardiac output changes after osmotic therapy in neurosurgical and neurocritical care patients: a systematic review of the clinical literature.

Authors:  Georgia Tsaousi; Elisabetta Stazi; Marco Cinicola; Federico Bilotta
Journal:  Br J Clin Pharmacol       Date:  2018-01-18       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.